{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01895439",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSUJCTC"
      },
      "Organization": {
        "OrgFullName": "University of Jordan",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis",
      "OfficialTitle": "Phase II Study: Use of Autologus Mesenchymal Stem Cells in Multiple Sclerosis Patients Who do Not Respond to Conventional Treatment"
    },
    "StatusModule": {
      "StatusVerifiedDate": "May 2017",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 2012"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "February 2016",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "February 2016",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "June 24, 2013",
      "StudyFirstSubmitQCDate": "July 3, 2013",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 10, 2013",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "May 1, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "May 2, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Fatima Jamali",
        "ResponsiblePartyInvestigatorTitle": "Researcher",
        "ResponsiblePartyInvestigatorAffiliation": "University of Jordan"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University of Jordan",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Expanding and priming Bone Marrow (BM)- Mesenchymal Stem Cells (MSCs) to a clinical scale according to Good Laboratory Practice using xenogenic free media instead of the previously used FCS.\nAssessing the safety of injecting autologous BM-MSCs to Multiple Sclerosis (MS)patients who fail to respond to conventional treatment.\nAssessing the therapeutic benefits on the participants in the trial as per established methods."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Multiple Sclerosis"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Bone marrow derived Mesenchymal Stem Cells",
          "Multiple Sclerosis",
          "Oligodendrocytes",
          "Neuroimmunology",
          "Autoimmune disease"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "13",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "MSCs injection",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Autologous bone marrow derived stem cells injected intrathecally to enrolled MS patients",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Autologous Mesenchymal Stem Cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Autologous Mesenchymal Stem Cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSCs injection"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "The number of patients with any relevant side effects observed",
            "PrimaryOutcomeDescription": "Assessing the safety of autologous Mesenchymal Stem Cells injection",
            "PrimaryOutcomeTimeFrame": "18 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Assessing the therapeutic benefits of the injected Autologous Mesenchymal Stem Cells by Magnetic Resonance Imaging (MRI) and ophthalmological tests.",
            "SecondaryOutcomeDescription": "For every patient tests would be performed at baseline and repeated at 3, 6, and 18 months post-injection",
            "SecondaryOutcomeTimeFrame": "18 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nA clinical diagnosis of definite MS according to the revised McDonald Criteria.\nExpanded Disability Status Scale (EDSS) â‰¤ 6\nFailure of standard medical therapy\nDisease duration of at least three years prior to enrollment.\n\nExclusion Criteria:\n\nPregnant and lactating women\nPrevious treatment with immunosuppressive agents in the last 12 months prior to enrollment\nRecent MS relapse in the month prior to enrollment\nTreatment with oral or parenteral steroids for any cause in the month prior to enrollment\nSignificant systemic medical disorders including cardiac, renal, hepatic, hematologic, immunologic or endocrine disorders\nPrevious treatment with interferons or glatiramer acetate in the 3 months prior to enrollment\nAny contra-indication for magnetic resonance imaging (MRI) or gadolinium contrast.\nPositive serology for HIV, Hepatitis B or Hepatitis C\nAny history of malignancy or exposure to radiation at any time prior to enrollment\nAny contra-indication to lumbar puncture\nSevere cognitive impairment that would interfere with the patient's ability to understand and sign the informed consent.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Abdallah Awidi, MD.",
            "OverallOfficialAffiliation": "Cell Therapy Center",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Said Dahbour, MD.",
            "OverallOfficialAffiliation": "Jordan University Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Cell Therapy Center, Jordan University Hospital",
            "LocationCity": "Amman",
            "LocationZip": "11942",
            "LocationCountry": "Jordan"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009103",
            "ConditionMeshTerm": "Multiple Sclerosis"
          },
          {
            "ConditionMeshId": "D000012598",
            "ConditionMeshTerm": "Sclerosis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000020278",
            "ConditionAncestorTerm": "Demyelinating Autoimmune Diseases, CNS"
          },
          {
            "ConditionAncestorId": "D000020274",
            "ConditionAncestorTerm": "Autoimmune Diseases of the Nervous System"
          },
          {
            "ConditionAncestorId": "D000009422",
            "ConditionAncestorTerm": "Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000003711",
            "ConditionAncestorTerm": "Demyelinating Diseases"
          },
          {
            "ConditionAncestorId": "D000001327",
            "ConditionAncestorTerm": "Autoimmune Diseases"
          },
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M11212",
            "ConditionBrowseLeafName": "Multiple Sclerosis",
            "ConditionBrowseLeafAsFound": "Multiple Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14567",
            "ConditionBrowseLeafName": "Sclerosis",
            "ConditionBrowseLeafAsFound": "Sclerosis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3781",
            "ConditionBrowseLeafName": "Autoimmune Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M21251",
            "ConditionBrowseLeafName": "Demyelinating Autoimmune Diseases, CNS",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M21247",
            "ConditionBrowseLeafName": "Autoimmune Diseases of the Nervous System",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6061",
            "ConditionBrowseLeafName": "Demyelinating Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}